{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:51:41Z","timestamp":1774893101782,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"9923","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/s0140-6736(13)62117-0","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T21:17:41Z","timestamp":1389820661000},"page":"1129-1137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":668,"title":["Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial"],"prefix":"10.1016","volume":"383","clinical-trial-number":[{"clinical-trial-number":"nct01461213","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Robert E","family":"MacLaren","sequence":"first","affiliation":[]},{"given":"Markus","family":"Groppe","sequence":"additional","affiliation":[]},{"given":"Alun R","family":"Barnard","sequence":"additional","affiliation":[]},{"given":"Charles L","family":"Cottriall","sequence":"additional","affiliation":[]},{"given":"Tanya","family":"Tolmachova","sequence":"additional","affiliation":[]},{"given":"Len","family":"Seymour","sequence":"additional","affiliation":[]},{"given":"K Reed","family":"Clark","sequence":"additional","affiliation":[]},{"given":"Matthew J","family":"During","sequence":"additional","affiliation":[]},{"given":"Frans P M","family":"Cremers","sequence":"additional","affiliation":[]},{"given":"Graeme C M","family":"Black","sequence":"additional","affiliation":[]},{"given":"Andrew J","family":"Lotery","sequence":"additional","affiliation":[]},{"given":"Susan M","family":"Downes","sequence":"additional","affiliation":[]},{"given":"Andrew R","family":"Webster","sequence":"additional","affiliation":[]},{"given":"Miguel C","family":"Seabra","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(13)62117-0_bib1","first-page":"191","article-title":"Ein Fall von Choroideremie","volume":"2","author":"Mauthner","year":"1872","journal-title":"Ber Naturwissensch-med Ver Inssbruck"},{"key":"10.1016\/S0140-6736(13)62117-0_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ng0592-109","article-title":"Aberrant splicing of the CHM gene is a significant cause of choroideremia","volume":"1","author":"Sankila","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/S0140-6736(13)62117-0_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/347674a0","article-title":"Cloning of a gene that is rearranged in patients with choroideraemia","volume":"347","author":"Cremers","year":"1990","journal-title":"Nature"},{"key":"10.1016\/S0140-6736(13)62117-0_bib4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/hmg\/3.7.1041","article-title":"Cloning and characterization of the human choroideremia gene","volume":"3","author":"van Bokhoven","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S0140-6736(13)62117-0_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.8380507","article-title":"Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase","volume":"259","author":"Seabra","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0140-6736(13)62117-0_bib6","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1167\/iovs.06-0424","article-title":"Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations","volume":"47","author":"Jacobson","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0140-6736(13)62117-0_bib7","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.0600236103","article-title":"Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants","volume":"103","author":"Sieving","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(13)62117-0_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1167\/iovs.12-10707","article-title":"High-resolution images of retinal structure in patients with choroideremia","volume":"54","author":"Syed","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0140-6736(13)62117-0_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","article-title":"Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years","volume":"130","author":"Jacobson","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0140-6736(13)62117-0_bib10","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(13)62117-0_bib11","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1089\/10430349950016942","article-title":"Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy","volume":"10","author":"Loeb","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/S0140-6736(13)62117-0_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","article-title":"AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial","volume":"10","author":"LeWitt","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/S0140-6736(13)62117-0_bib13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0042-6989(02)00389-9","article-title":"Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus","volume":"43","author":"Anand","year":"2003","journal-title":"Vision Res"},{"key":"10.1016\/S0140-6736(13)62117-0_bib14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00109-013-1006-4","article-title":"Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo","volume":"91","author":"Tolmachova","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/S0140-6736(13)62117-0_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of Leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/S0140-6736(13)62117-0_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0161-6420(83)34382-7","article-title":"Inter-observer variation in refraction and visual acuity measurement using a standardized protocol","volume":"90","author":"Klein","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/S0140-6736(13)62117-0_bib17","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1167\/iovs.08-2926","article-title":"Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease","volume":"50","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0140-6736(13)62117-0_bib18","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(13)62117-0_bib19","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/S0140-6736(13)62117-0_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMc0903652","article-title":"Vision 1 year after gene therapy for Leber's congenital amaurosis","volume":"361","author":"Cideciyan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(13)62117-0_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1034\/j.1600-0420.2000.078004483.x","article-title":"Choroideremia associated with subretinal neovascular membrane","volume":"78","author":"Endo","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/S0140-6736(13)62117-0_bib22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ejhg.2011.86","article-title":"A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement","volume":"19","author":"Bowne","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S0140-6736(13)62117-0_bib23","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1167\/iovs.09-4892","article-title":"Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia","volume":"51","author":"Tolmachova","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S0140-6736(13)62117-0_bib24","doi-asserted-by":"crossref","first-page":"88ra54","DOI":"10.1126\/scitranslmed.3002103","article-title":"Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey","volume":"3","author":"Vandenberghe","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/S0140-6736(13)62117-0_bib25","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(13)62117-0_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.0.CO;2-D","article-title":"Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene","volume":"9","author":"van den Hurk","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1016\/S0140-6736(13)62117-0_bib27","first-page":"540","article-title":"An analysis of retinal gene therapy clinical trials","volume":"11","author":"MacLaren","year":"2009","journal-title":"Curr Opin Mol Ther"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673613621170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673613621170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T05:24:27Z","timestamp":1538889867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673613621170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":27,"journal-issue":{"issue":"9923","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0140673613621170"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(13)62117-0","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(13)62117-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(14)60033-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}